Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer

Progression of aggressive prostate cancers (PCa) with androgen receptor splice variants or neuroendrocrine features is currently untreatable in the clinic. Therefore novel therapies are urgently required. We conducted RNA-seq using tumors from a unique murine transplant mouse model which spontaneous...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Kirk, Jason S., Schaarschuch, Kevin, Dalimov, Zafardjan, Lasorsa, Elena, Ku, ShengYu, Ramakrishnan, Swathi, Hu, Qiang, Azabdaftari, Gissou, Wang, Jianmin, Pili, Roberto, Ellis, Leigh
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2014
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413643/
https://ncbi.nlm.nih.gov/pubmed/25605014
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi